Redsense announces CEO succession date
Redsense Medical announces that newly appointed Pontus Nobréus will take over as CEO of the Company starting the 1[st] of August 2022. Outgoing CEO Patrik Byhmer, co-founder and largest shareholder of Redsense, will transition into a new role as Chairman of the Board. The agreement was announced in May but an exact date when Nobréus would assume responsibilities and take over the helm at Redsense was still to be determined. Nobréus combines a track record of driving sales through well-targeted commercialization with an unwavering commitment to innovation that truly benefits patients, and